Avoiding Amputation: Medical-Grade Honey's Role in Diabetic Foot Care

Products: L-Mesitran Soft
Case study performed by: Daniela Chrysostomou, Wound Clinic Health@45, Johannesburg, South Africa.

A 44-year-old female with type 1 diabetes presented with a three-month-old, heavily infected diabetic foot ulcer on her heel. Despite adhering to diabetic care protocols, the infection was severe enough that amputation was considered. The ulcer was colonized by Pseudomonas aeruginosa, showing green staining and producing a foul odour.

Method: The treatment involved applying a thick layer of L-Mesitran Soft, a medical-grade honey, after limited sharp debridement. The wound was then covered with a secondary absorbent dressing and regularly changed, with special footwear to reduce pressure on the ulcer.

Results: Initial results showed rapid improvement: the foul odour disappeared by day 3, and significant granulation tissue formed. Continued treatment over a month led to a strong reduction in wound size and enhanced both the physical and mental quality of life for the patient.

44 yo woman
Clinical Case of a Pseudomonas-infected diabetic ulcer, located on the heel, treated with L-Mesitran. Soft. (a) Picture at the start of L-Mesitran Soft treatment on Day 0. (b) Wound after one month of treatment on Day 33.

Discussion: L-Mesitran Soft proved effective in fighting biofilms and infection without fostering antibiotic resistance. Its low pH and osmotic action not only cleared the infection but also promoted healthy tissue growth, showing its superiority over traditional treatments.

Conclusion: This case demonstrates the powerful healing properties of medical-grade honey in treating severe diabetic foot ulcers. L-Mesitran Soft’s ability to rapidly improve complex infections offers a promising alternative to conventional antibiotics, potentially saving limbs from amputation.

Curious about our products?

Medical Professionals can request free samples to try our products out.